Clincosm LogoSign in Get a demo

hodgkin disease

Showing 1 - 25 of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)

Not yet recruiting
  • Hodgkin Disease
  • Morphological and functional magnetic resonance imaging (MRI)
  • Neuropsychological assessment
  • Arras, France
  • +3 more
Oct 31, 2023

Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Low-field magnetic resonance imaging
  • +3 more
  • Erlangen, Bavaria, Germany
    Department of Pediatrics and Adolescent Medicine
Oct 23, 2023

Clinical, Laboratory and Epidemiologic Characterization of

Recruiting
  • Waldenstrom Macroglobulinemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Resting Heart Rate and Heart Rate Variability in Survivors of

    Active, not recruiting
    • Hodgkin Disease
      • Memphis, Tennessee
        Kirsten Ness
      Jan 23, 2023

      Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

      Recruiting
      • Hodgkin Disease
      • +5 more
      • MABEL CTLs
      • +2 more
      • Houston, Texas
      • +1 more
      Jan 13, 2023

      Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

      Completed
      • Multiple Myeloma
      • +11 more
      • Pre-biotic foods/drinks
      • Charlottesville, Virginia
        University of Virginia
      Jan 2, 2023

      Patterns and Disease Control in cHL and sALCL in Routine

      Completed
      • Hodgkin Disease
      • Lymphoma, Large-cell, Anaplastic
        • Astrakhan, Russian Federation
        • +49 more
        Dec 19, 2022

        Breast Tumor, Prostatic Tumor, Colorectal Tumors Trial in United States (AH-HA Tool in the EPIC EHR)

        Enrolling by invitation
        • Breast Neoplasm
        • +5 more
        • AH-HA Tool in the EPIC EHR
        • Fort Smith, Arkansas
        • +11 more
        Dec 8, 2022

        Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

        Not yet recruiting
        • Pediatric Cancer
        • +11 more
        • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
        • Milwaukee, Wisconsin
          Children's Wisconsin
        Sep 14, 2022

        Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

        Recruiting
        • Acute Myelogenous Leukemia
        • +4 more
        • Stem cell transplantation
        • +3 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        Aug 23, 2022

        Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)

        Recruiting
        • Hodgkin Disease
        • +2 more
        • pembrolizumab
        • Favezelimab
        • Gilbert, Arizona
        • +24 more
        Aug 18, 2022

        Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)

        Not yet recruiting
        • Lymphoma, Non-Hodgkin
        • Hodgkin Disease
        • Phoenix, Arizona
        • +53 more
        Aug 17, 2022

        Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)

        Recruiting
        • Lung Cancer
        • +8 more
        • Home-based cardiac rehabilitation
        • Saint Louis, Missouri
          Washington University School of Medicine
        Aug 9, 2022

        Relapsed or Refractory CD30+ Malignancies When Re-treated With

        Completed
        • Hodgkin Disease
        • Lymphoma, T-Cell, Cutaneous
        • No Intervention
        • San Bartolome, Alicante, Spain
        • +29 more
        Jul 28, 2022

        Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)

        Active, not recruiting
        • Hodgkin Disease
        • Nivolumab
        • +2 more
        • Birmingham, Alabama
        • +77 more
        Jul 21, 2022

        Biospecimen Procurement for Center for Immuno-Oncology

        Recruiting
        • Multiple Myeloma
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jul 13, 2022

          Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)

          Completed
          Has Results
          • Hodgkin Disease
          • Brentuximab vedotin
          • +3 more
          • Aurora, Colorado
          • +13 more
          Jun 17, 2022

          Brazilian Prospective Hodgkin Lymphoma Registry

          Recruiting
          • Hodgkin Lymphoma
          • Hodgkin Disease
            • Rio de Janeiro, Brazil
              Universidade Federal Do Rio de Janeiro
            May 16, 2022

            Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal

            Recruiting
            • Young Adults
            • +2 more
            • Indirect calorimetric test during submaximal exercise
            • Clermont-Ferrand, France
              CHU de Clermont-Ferrand
            May 3, 2022

            Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)

            Recruiting
            • Late Effects
            • +8 more
            • PASCA intervention
            • Lyon, France
              Centre Leon Berard
            Mar 15, 2022

            Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)

            Active, not recruiting
            • Hodgkin Disease
            • +8 more
            • ATLCAR.CD30 cells
            • Chapel Hill, North Carolina
            • +1 more
            Mar 2, 2022

            Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

            Active, not recruiting
            Has Results
            • Acute Myelogenous Leukemia
            • +10 more
            • Atlanta, Georgia
            • +2 more
            Feb 9, 2022

            Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

            Active, not recruiting
            • Hodgkin Disease
            • Houston, Texas
              Texas Children's Hospital
            Jan 19, 2022

            Hodgkin Disease Trial in Belgium, France (Brentuximab Vedotin, Etoposide, Carboplatine)

            Completed
            • Hodgkin Disease
            • Brentuximab Vedotin
            • +3 more
            • Bruxelles, Belgium
            • +18 more
            Dec 6, 2021